A 41-year-old woman with no significant past medical history presents with a solitary nodule on her lower left ankle. The lesion has been growing over the past several months. The patient first ...

Researchers explored the risks for basal cell carcinoma, squamous cell carcinoma, and melanoma in patients who underwent BMT.

Dr. Richard “Rick" Winneker discussed advice that he would provide to patients faced with a myeloproliferative neoplasm ...

Volrustomig is under clinical development by AstraZeneca and currently in Phase II for Malignant Neoplasms. According to GlobalData, Phase II drugs for Malignant Neoplasms does not have sufficient ...

A patient with MPN urges others to ask questions about treatment options, which may also include inquiring about clinical ...

ADPA-2AFP is under clinical development by Adaptimmune Therapeutics and currently in Phase I for Malignant Neoplasms. According to GlobalData, Phase I drugs for Malignant Neoplasms does not have ...